| 前收市價 | 7.16 |
| 開市 | 7.25 |
| 買盤 | 7.25 x 1200 |
| 賣出價 | 7.33 x 600 |
| 今日波幅 | 7.18 - 7.43 |
| 52 週波幅 | 2.76 - 19.20 |
| 成交量 | |
| 平均成交量 | 9,072,145 |
| 市值 | 750.053M |
| Beta 值 (5 年，每月) | 1.77 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -4.69 |
| 業績公佈日 | 2024年8月09日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 4.33 |
- InvestorPlace
Canopy Growth Stock: This Pot Pick Could Hit $15 Sooner Than You Think
Canopy Growth (NASDAQ:CGC) is a premier Canadian cannabis company. Granted, Canopy Growth isn’t in perfect financial condition. That’s likely true for every canna-business. Canopy Growth stock can rise as the company improves. I’m not suggesting that 2024 will be bubble-icious like 2018 was. Canopy Growth’s shareholders should be cautious and avoid price chasing and over-investing. Canopy Growth’s recent results show progress in closing the profitability gap. Canopy Growth: Don’t Expect Too Much
Barrons.comPot Stocks Surge as Biden ‘Reschedules’ Marijuana
A change in classification is moving closer to reality. Multistate weed sellers would be the immediate beneficiaries.
InvestorPlaceThe 3 Best Cannabis Stocks to Buy Now: September 2023
With cannabis usage continuing to rise, now could be an opportune time to invest in marijuana stocks. Over 52 million Americans currently use cannabis, and legalization seems inevitable as more states approve recreational and medical use. However, investing in cannabis stocks is extremely risky and highly speculative. I’d recommend taking only a small position in most names, as the regulatory environment remains uncertain. Though public opinion has shifted, full federal legalization in the U.S.
